These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 28036035)
1. Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus. Wang H; Cao J; Lai X Molecules; 2016 Dec; 22(1):. PubMed ID: 28036035 [TBL] [Abstract][Full Text] [Related]
2. Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity. Tanaka A; Tsukamoto H; Mitoma H; Kiyohara C; Ueda N; Ayano M; Ohta S; Inoue Y; Arinobu Y; Niiro H; Horiuchi T; Akashi K Arthritis Res Ther; 2012 Nov; 14(6):R244. PubMed ID: 23140401 [TBL] [Abstract][Full Text] [Related]
3. Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus. Brilland B; Bach-Bunner M; Gomes CN; Larochette V; Foucher E; Plaisance M; Saulnier P; Costedoat-Chalumeau N; Ghillani P; Belizna C; Delneste Y; Augusto JF; Jeannin P Front Immunol; 2021; 12():663192. PubMed ID: 34054830 [TBL] [Abstract][Full Text] [Related]
4. Elevated Serum Interleukin-34 Level in Patients with Systemic Lupus Erythematosus Is Associated with Disease Activity. Xie HH; Shen H; Zhang L; Cui MY; Xia LP; Lu J Sci Rep; 2018 Feb; 8(1):3462. PubMed ID: 29472590 [TBL] [Abstract][Full Text] [Related]
5. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity. El-Banna HS; El Khouly RM; Gado SE Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692 [TBL] [Abstract][Full Text] [Related]
6. Elevated plasma interleukin-37 levels in systemic lupus erythematosus patients. Wu GC; Li HM; Wang JB; Leng RX; Wang DG; Ye DQ Lupus; 2016 Oct; 25(12):1377-80. PubMed ID: 27125292 [TBL] [Abstract][Full Text] [Related]
7. Collagen triple helix repeat containing-1: a novel biomarker associated with disease activity in Systemic lupus erythematosus. Wu Q; Yang Q; Sun H Lupus; 2018 Nov; 27(13):2076-2085. PubMed ID: 30336754 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus. Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928 [TBL] [Abstract][Full Text] [Related]
9. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE. Tripathy R; Panda AK; Das BK Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568 [TBL] [Abstract][Full Text] [Related]
10. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies. Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865 [TBL] [Abstract][Full Text] [Related]
11. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis. Du Y; Wu X; Chen M; Wang W; Xv W; Ye L; Wu D; Xue J; Sun W; Luo J; Wu H Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160 [TBL] [Abstract][Full Text] [Related]
12. Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. Mok MY; Huang FP; Ip WK; Lo Y; Wong FY; Chan EY; Lam KF; Xu D Rheumatology (Oxford); 2010 Mar; 49(3):520-7. PubMed ID: 20026564 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients. He D; Liu M; Liu B Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585 [TBL] [Abstract][Full Text] [Related]
14. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time. Becker-Merok A; Nikolaisen C; Nossent HC Lupus; 2006; 15(9):570-6. PubMed ID: 17080911 [TBL] [Abstract][Full Text] [Related]
15. Increased serum IL-36α and IL-36γ levels in patients with systemic lupus erythematosus: Association with disease activity and arthritis. Mai SZ; Li CJ; Xie XY; Xiong H; Xu M; Zeng FQ; Guo Q; Han YF Int Immunopharmacol; 2018 May; 58():103-108. PubMed ID: 29571080 [TBL] [Abstract][Full Text] [Related]
17. Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus. Lin J; Li N; Chen H; Liu C; Yang B; Ou Q Medicine (Baltimore); 2015 May; 94(19):e834. PubMed ID: 25984669 [TBL] [Abstract][Full Text] [Related]
18. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4. Julkunen H; Ekblom-Kullberg S; Miettinen A Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294 [TBL] [Abstract][Full Text] [Related]
19. Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients. Duarte AL; Dantas AT; de Ataíde Mariz H; dos Santos FA; da Silva JC; da Rocha LF; Galdino SL; Galdino da Rocha Pitta M Mol Biol Rep; 2013 Aug; 40(8):4889-92. PubMed ID: 23645091 [TBL] [Abstract][Full Text] [Related]
20. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus. Thanadetsuntorn C; Ngamjanyaporn P; Setthaudom C; Hodge K; Saengpiya N; Pisitkun P Sci Rep; 2018 Feb; 8(1):2620. PubMed ID: 29422675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]